Impact of the UK COVID-19 pandemic on HbA1c testing and its implications for diabetes diagnosis and management

Autor:	Ian Halsall, Anthony A. Fryer, Neil Gaskell, Mike Stedman, Jonathan Scargill, Lewis Green, David Holland, Adrian H Heald, Pensee Wu, Christopher J. Duff, Fahmy Hanna
Rok vydání:	2020
Předmět:	medicine.medical_specialty Increased risk Coronavirus disease 2019 (COVID-19) Collateral Diabetes diagnosis business.industry Diabetes mellitus Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Pandemic medicine Intensive care medicine medicine.disease business
DOI:	10.22541/au.160770263.30907582/v1
Popis:	Our findings illustrate the widespread collateral impact of implementing measures to mitigate the impact of COVID-19 in people with, or being investigated for diabetes mellitus (DM). Ironically, failure to focus of the wider implications for people with DM and other groups with long-term conditions, may place them at increased risk of poor outcomes from SARS-CoV-2 infection itself, irrespective of the implications for their longer-term health prospects.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::0f6a0de58decf9e2911a7967aa5ee541 https://doi.org/10.22541/au.160770263.30907582/v1 Zobrazit plný text záznamu